Clinical studies recruiting near Homestead

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · Homestead Associates in Research, Inc. · AbbVie · NCT06602479 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
Phase 3 · Nexus Clinical Research Center, Merz Investigational Site #0 · Merz Therapeutics GmbH · NCT07018700 Study of Aritinercept in Patients With Generalized Myasthenia Gravis
Phase 1/Phase 2 · Aurinia Investigational Site · Aurinia Pharmaceuticals Inc. · NCT07596901 A Study to Learn About How a New Pneumococcal Vaccine Works in Infants.
Phase 3 · C & R Research Services USA · Pfizer · NCT07629440 A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Phase 2 · Homestead Associates in Research · Vertex Pharmaceuticals Incorporated · NCT07501702 A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic Migraine
Phase 3 · Nexus Clinical Research Center, Merz Investigational Site #0 · Merz Therapeutics GmbH · NCT07018713 A Study to Evaluate Solrikitug in Participants With COPD (ZION)
Phase 2 · Homestead Associates in Research Inc. · Uniquity One (UNI) · NCT06496620 A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
Phase 3 · 89bio Clinical Study Site · 89bio, Inc. · NCT06419374 Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Phase 3 · Advanced Research Institute of Miami · Intra-Cellular Therapies, Inc. · NCT06372964 Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associate
Phase 3 · Nexus Clinical Research Center- NRC · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05980949 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al
Phase 3 · Local Institution - 2606 · Bristol-Myers Squibb · NCT07011745 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C
Phase 3 · Global Research Associates · Boehringer Ingelheim · NCT06632457 Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease o
Phase 3 · Clinical Trial Site · Alnylam Pharmaceuticals · NCT07181109 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
Phase 2 · Homestead Associates in Research- Site Number : 8400012 · Sanofi · NCT06637631 A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Gener
Phase 3 · Homestead Assoc In Research Inc · Novartis Pharmaceuticals · NCT06744920 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 1049 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT05511363 A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
Phase 3 · Homestead Associates in Research Inc · argenx · NCT06920004 A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism
Phase 3 · MBX Biosciences Investigational Site · MBX Biosciences · NCT07699471 A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT
Phase 3 · Local Institution - 0150 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT06126224 A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Phase 2 · Homestead Associates in Research Inc · Intra-Cellular Therapies, Inc. · NCT06540833 A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Phase 2 · Homestead Associates In Research Inc · Amgen · NCT06570798 A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07221188 A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopul
Phase 3 · Research Site · AstraZeneca · NCT06283966 A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D
Phase 3 · Research Site · AstraZeneca · NCT06883305 Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Ch
Phase 3 · Advanced Research Institute of Miami /ID# 230292 · AbbVie · NCT05125302 A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a
Phase 3 · Research Site · AstraZeneca · NCT07000357 LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or A
Phase 3 · Global Research Associates · Boehringer Ingelheim · NCT06632444 A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Ep
Phase 3 · Advanced Research Institute of Miami /ID# 228222 · AbbVie · NCT04777357 A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
Phase 2 · Clinical Site · MapLight Therapeutics · NCT06887192 Secukinumab Open Label Roll-over Extension Protocol
Phase 4 · Homestead Assoc In Research Inc · Novartis Pharmaceuticals · NCT04638647

Look up another city

Look up another condition